Integer Holdings Corporation (NYSE:ITGR) Receives $102.00 Average Target Price from Analysts

Shares of Integer Holdings Corporation (NYSE:ITGR) have received an average recommendation of “Hold” from the ten ratings firms that are presently covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $102.00.

Several research firms have recently commented on ITGR. Citigroup upped their price objective on shares of Integer from $75.00 to $92.00 and gave the company a “neutral” rating in a report on Friday, February 20th. Weiss Ratings upgraded Integer from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday. Truist Financial upped their target price on Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Friday, February 20th. Wall Street Zen downgraded Integer from a “buy” rating to a “hold” rating in a report on Sunday, January 25th. Finally, Wells Fargo & Company raised their price objective on shares of Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research note on Friday, February 20th.

Integer Price Performance

NYSE ITGR opened at $86.89 on Wednesday. The company has a market cap of $2.99 billion, a price-to-earnings ratio of 30.28, a PEG ratio of 1.48 and a beta of 0.77. The company has a debt-to-equity ratio of 0.69, a current ratio of 3.32 and a quick ratio of 2.23. The stock’s fifty day moving average price is $83.91 and its 200 day moving average price is $87.58. Integer has a 1 year low of $62.00 and a 1 year high of $127.56.

Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 earnings per share for the quarter, beating the consensus estimate of $1.70 by $0.06. Integer had a return on equity of 13.26% and a net margin of 5.55%.The business had revenue of $472.06 million for the quarter, compared to the consensus estimate of $462.73 million. During the same quarter in the previous year, the business earned $1.43 EPS. The company’s quarterly revenue was up 5.0% compared to the same quarter last year. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. As a group, equities research analysts forecast that Integer will post 6.01 earnings per share for the current year.

Integer announced that its board has approved a share buyback plan on Tuesday, November 4th that allows the company to buyback $200.00 million in outstanding shares. This buyback authorization allows the medical equipment provider to purchase up to 8.3% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s leadership believes its shares are undervalued.

Institutional Trading of Integer

Institutional investors and hedge funds have recently made changes to their positions in the business. Salomon & Ludwin LLC purchased a new stake in Integer in the 3rd quarter worth $26,000. Global Retirement Partners LLC raised its position in shares of Integer by 293.8% during the 3rd quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock worth $33,000 after purchasing an additional 238 shares during the last quarter. CWM LLC lifted its stake in Integer by 46.1% in the 2nd quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 112 shares in the last quarter. MAI Capital Management boosted its holdings in Integer by 220.9% in the 2nd quarter. MAI Capital Management now owns 369 shares of the medical equipment provider’s stock worth $45,000 after buying an additional 254 shares during the last quarter. Finally, TD Private Client Wealth LLC increased its stake in Integer by 1,037.5% during the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock worth $36,000 after buying an additional 415 shares in the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.